Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Comparison Of Medical Imaging Choices Finds Ultrasound To Be The Most Cost Efficient
In comparing ultrasound with other medical imaging methods such as MRI and CT scans, a literature review of published studies in the May/June issue of Journal of Diagnostic Medical Sonography (JDMS) describes the use of ultrasound to provide an accurate diagnosis more cost effectively than the alternatives.
generic viagra online
Could Your Mouth, Not The Food You Put Into It Be The Secret To The Size Of Your Waistline?
Oral healthcare could hold the key to beating obesity according to new dental research*.
News of the day
Baptist Conference Addresses HIV/AIDS In Black Community
Fear, religious beliefs and cultural differences are among the reasons why blacks do not get tested for HIV, participants of the National Baptist Convention USA"s annual Congress of Christian Education conference being held in Detroit, said on Monday, the Detroit Free Press reports. As part of the five-day conference, religious leaders discussed ways to address the high rates of HIV and AIDS among the black community. Participants also said that concerns of racism by medical professionals may be a reason why blacks do not get tested. Simone Phillips of the St. Louis chapter of the American Red Cross said, "A lot of people are leery" in the black community and "we [need] to get rid of the stigma" surrounding HIV/AIDS (Warikoo, Detroit Free Press, 6/23).
Sexual Health

Experts Discuss Scientific, Public Health Implications Of H1N1 Flu Outbreak At Special NYAS Symposium

As H1N1 (swine) flu continues to spread, it"s clear that the worldwide outbreak of this new virus remains a rigorous test for science and public health. Regardless of whether the outbreak reaches pandemic levels, H1N1 has much to teach us about the evolving nature of such viruses and how to better prepare for future global outbreaks. On May 28, the New York Academy of Sciences (NYAS) will host a symposium on H1N1 influenza, with leading experts in virology, epidemiology, public health, and vaccine development. The event will review the latest research on how this novel virus operates and efforts to track and treat the outbreak. Understanding the pathogenicity and transmission of viruses like H1N1 will be key to developing improved methods of prevention and control of future outbreaks. This program will be webcast as a live Webinar, providing an opportunity for interested audiences outside the New York area to participate in this exciting and timely discussion. WHAT Human Swine Flu (H1N1) and Novel Influenza Pandemics, a NYAS symposium, organized by the Academy"s Emerging Infectious Diseases and Microbiology Discussion Group, sponsored by Sanofi Pasteur, Centrum, Clorox and VaxInnate. WHO Leading authorities on virology, vaccine development and public health, including: - Doris Bucher, Associate Professor of Microbiology and Immunology at New York Medical College, whose lab is one of just three worldwide that produce "seed" viruses for the influenza vaccine (organizer). - Nancy Cox, Chief, Influenza Branch of the Centers for Disease Control and Prevention and Director, World Health Organization Centre for Influenza Reference. - Scott Harper, Medical Epidemiologist at the Zoonotic, Influenza, and Vectorborne Diseases Unit of the Bureau of Communicable Disease, New York City Department of Health and Mental Hygiene. - Edwin D. Kilbourne, Emeritus Professor of Microbiology and Immunology at New York Medical College; developer of the first genetically engineered vaccine (keynote speaker). - Rino Rappuoli, Global Head of Vaccines Research, Novartis Vaccines & Diagnostics. - Kanta Subbarao, Senior Investigator at the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Disease. - John Treanor, Professor of Medicine, Microbiology and Immunology at the University of Rochester School of Medicine and Dentistry and Director of its Vaccine and Treatment Evaluation Unit. - James Matthews, Sanofi Pasteur (moderator). WHEN May 28, 12:30 pm to 5:30 pm (reception to follow). WHERE The New York Academy of Sciences, 7 World Trade Center, 40th floor, 250 Greenwich St., New York, NY, 10007. New York Academy of Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009